{
  "id": "dip_health_rec_pastpapers_archive_1769461208460_17a63a18-3e69-490b-8328-39e274f7f6ef_2021j_fqe",
  "title": "Epidemiology - FQE July 2021 | Past Papers",
  "subjectId": "dip_health_rec_pastpapers_archive_1769461208460",
  "topicId": "17a63a18-3e69-490b-8328-39e274f7f6ef",
  "topicName": "Epidemiology past papers",
  "description": "KMTC Final Qualifying Examination for Diploma in Health Records and Information Technology - Epidemiology Paper, July 2021",
  "isPaid": true,
  "timeLimit": 120,
  "passingScore": 70,
  "version": 1,
  "order": 4,
  "questions": [
    {
      "id": "q1_1865d006",
      "question": "Which of the following is not a type of analytic studies?",
      "points": 10,
      "explanation": "Explanation: Cross-sectional surveys are primarily descriptive studies used to generate hypotheses, although they can sometimes be analytical. Case-control and Cohort studies are the classic analytic designs. \"Observational studies\" is a broad category that includes both descriptive and analytic types, so it's not a specific \"type\" of analytic study itself, but Cross-sectional is the most distinctively descriptive option listed.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Cross sectional surveys",
          "isCorrect": true
        },
        {
          "id": "b",
          "text": "b) Observational studies",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Case control studies",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Cohort studies",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q2_ffb1d7cb",
      "question": "--- studies looks forward from an exposure to outcome",
      "points": 10,
      "explanation": "Explanation: Prospective studies (synonymous with prospective cohort studies) look forward in time from exposure to outcome. While \"Cohort\" is also correct, \"Prospective\" describes the directionality explicitly asked for.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Retrospective studies",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Cohort studies",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Case control studies",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Prospective studies",
          "isCorrect": true
        }
      ]
    },
    {
      "id": "q3_1fecbf3a",
      "question": "---- incidence provides an estimate of the probability that an individual will develop a disease during a specific period of time",
      "points": 10,
      "explanation": "Explanation: Cumulative Incidence (Risk) estimates the probability/risk of an individual developing the disease over a specified time period. Incidence Density (c) measures the rate (speed) of new cases.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Gross",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Net",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Density",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Cumulative",
          "isCorrect": true
        }
      ]
    },
    {
      "id": "q4_8a5875d6",
      "question": "Unusual medical occurrences that can represent the first clues in the identification of new diseases or adverse effects of exposure are documented inform of",
      "points": 10,
      "explanation": "Explanation: A Case Report documents a single unusual medical occurrence. This is often the first step in identifying new diseases (e.g., the first reports of Kaposi's sarcoma in young men signaling HIV).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Case manuals",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Case report",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Case series",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Case data",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q5_907183be",
      "question": "---- refers to the application of a test to people who are yet asymptomatic for the purpose of classifying them with respect to their likelihood of getting a certain disease",
      "points": 10,
      "explanation": "Explanation: Screening is the presumptive identification of unrecognized disease (asymptomatic phase) by applying tests to sort people into likely ill and likely healthy groups.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Testing",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Diagnosis",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Screening",
          "isCorrect": true
        },
        {
          "id": "d",
          "text": "d) Validation",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q6_c443f89d",
      "question": "Which type of trials involves evaluation of whether an agent or procedure reduces the risk of developing a disease",
      "points": 10,
      "explanation": "Explanation: Preventive (Prophylactic) trials evaluate agents (like vaccines) given to healthy individuals to prevent disease development. Therapeutic trials treat those who are already sick.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Therapeutic",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Preventive",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Control",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Secondary",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q7_70798620",
      "question": "What is the type of prevention that aims at reducing the impact of a disease?",
      "points": 10,
      "explanation": "Explanation: Tertiary prevention aims to reduce the impact, complications, and disability of an established disease (rehabilitation). Secondary prevention aims at early detection/cure. Primary aims at preventing onset.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Primary",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Secondary",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Tertiary",
          "isCorrect": true
        },
        {
          "id": "d",
          "text": "d) Middle",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q8_87be3554",
      "question": "An individual who harbors the disease organism but is not infected is referred to as",
      "points": 10,
      "explanation": "Explanation: Standard definition: A carrier harbors the organism and can transmit it but shows no symptoms. Technically they are infected (colonized), but not diseased. The question phrasing \"not infected\" is epidemiologically imprecise but \"Carrier\" is the intended answer for \"harbors organism but no disease\".",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Asymptomatic",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Symptomatic",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Latent",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Carrier",
          "isCorrect": true
        }
      ]
    },
    {
      "id": "q9_931f1797",
      "question": "--- is the ability of the test to identify correctly those who have a disease",
      "points": 10,
      "explanation": "Explanation: Sensitivity = True Positives / (True Positives + False Negatives). It measures the ability to correctly identify those with the disease.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Validity",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Reliability",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Sensitivity",
          "isCorrect": true
        },
        {
          "id": "d",
          "text": "d) Specificity",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q10_6c4b2aac",
      "question": "Another name for reliability of a test is",
      "points": 10,
      "explanation": "Explanation: Reliability refers to the consistency or reproducibility of a test. If you repeat the test, do you get the same result? Hence, Repeatability/Reproducibility.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Sensitivity",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Variation",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Correctness",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Repeatability",
          "isCorrect": true
        }
      ]
    },
    {
      "id": "q11_b4310bed",
      "question": "Which one of the following is a good index of the severity of a short term acute disease?",
      "points": 10,
      "explanation": "Explanation: Case Fatality Rate (CFR) measures the proportion of diagnosed cases that die from the disease. It is the standard measure of disease severity/virulence for acute conditions (e.g., Ebola, Cholera).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Cause of specific disease",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) 5-year survival",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Case fatality",
          "isCorrect": true
        },
        {
          "id": "d",
          "text": "d) Standardized mortality ratio",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q12_b9893db8",
      "question": "Randomization can be achieved by use of one of the following except",
      "points": 10,
      "explanation": "Explanation: Computers (algorithms) and Random number tables are standard tools for randomization. \"Epidemiology tables\" is a vague term, likely referring to data presentation tables (2x2 tables), which are not used to generate random sequences.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Epidemiology tables",
          "isCorrect": true
        },
        {
          "id": "b",
          "text": "b) Computers",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Random number tables",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Random numbers",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q13_9e6f56db",
      "question": "The major purpose of random assignment in clinical trials is to",
      "points": 10,
      "explanation": "Explanation: Randomization ensures that known and unknown confounders are equally distributed between groups, eliminating selection bias by the investigator in assigning treatment.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Facilitate double blinding",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Reduce selection bias in the allocation of treatment",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Facilitate the measurement of outcome variables",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Help ensure that the study subjects are representative of the general population",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q14_1e72a1e8",
      "question": "Another name for odd ratio is",
      "points": 10,
      "explanation": "Explanation: The Odds Ratio is sometimes referred to as the Relative Odds or the Cross-Product Ratio (ad/bc).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Against Odds",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Odds Risk",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Relative Odds",
          "isCorrect": true
        },
        {
          "id": "d",
          "text": "d) Risk Odds",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q15_a1af8081",
      "question": "------- is the amount or proportion of disease incidence that can be attributed to a specific exposure",
      "points": 10,
      "explanation": "Explanation: Attributable Risk (Risk Difference) quantifies the amount (absolute excess) of disease risk that is due to the exposure.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Attributable odds",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Attributable risk",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Attributable Risk Percent",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Attributable Risk",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q16_9e0063ab",
      "question": "All the following are important criteria when making causal inferences except",
      "points": 10,
      "explanation": "Explanation: Based on Hill's Criteria of Causality: Consistency (a), Strength (c), and Biological Gradient/Dose-response (d) are core criteria. \"Prediction of events\" is a goal of science but not one of Hill's specific criteria for inferring causality from data.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Constancy with existing knowledge",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Prediction of events",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Strength of association",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Dose response relationship",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q17_83748336",
      "question": "---- is a systematic relationship error in design conduct or analysis of a study that results in a mistaken estimate of an exposure effect",
      "points": 10,
      "explanation": "Explanation: Bias is defined as systematic error in the design, conduct, or analysis of a study. Confounding (d) is a mixing of effects, not necessarily a design error.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Interaction",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Inference",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Bias",
          "isCorrect": true
        },
        {
          "id": "d",
          "text": "d) Confounder",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q18_7f60d9ac",
      "question": "The extent to which a specific health care treatment, service or procedure, program or other intervention produces a beneficial result under ideal control is called",
      "points": 10,
      "explanation": "Explanation: - Efficacy: Works under ideal/controlled conditions. - Effectiveness: Works under real-world conditions. - Efficiency: Works with optimal resource use (cost-benefit).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Efficacy",
          "isCorrect": true
        },
        {
          "id": "b",
          "text": "b) Effectiveness",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Effect modification",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Efficiency",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q19_b520c054",
      "question": "Which one of the following is termed as a fictitious rate?",
      "points": 10,
      "explanation": "Explanation: A Standardized Rate (adjusted rate) is a hypothetical or \"fictitious\" number. It is calculated to allow comparison between populations with different age structures, but it does not represent the actual rate observed in the population (unlike crude or specific rates).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) A prevalence rate",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Incidence rate",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Standardize rate",
          "isCorrect": true
        },
        {
          "id": "d",
          "text": "d) Infant mortality rate",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q20_e09a3474",
      "question": "------ is a means by which a causal factor leads to an outcome",
      "points": 10,
      "explanation": "Explanation: An intervening variable (or mediator) is part of the causal pathway: Exposure -> Intervening Variable -> Outcome.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Intervening variable",
          "isCorrect": true
        },
        {
          "id": "b",
          "text": "b) Validity",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Modifier",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Confounder",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q21_ee151da9",
      "question": "Which of the following is a measure of risk of having a risk factor?",
      "points": 10,
      "explanation": "Explanation: In Case-Control studies (where we start with the disease), we look back to see who had the risk factor. The Odds Ratio compares the odds of having the exposure (risk factor) in cases vs controls.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Kappa",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Odds ratio",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Relative risk",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Risk ratio",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q22_fcb2d16a",
      "question": "The administration of human immune globulin after exposure of Hepatitis B is an example of",
      "points": 10,
      "explanation": "Explanation: Administering pre-formed antibodies (immune globulin) provides immediate, temporary protection. This is Artificially Acquired Passive Immunity.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Herd immunity",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Acute immunity",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Passive immunity",
          "isCorrect": true
        },
        {
          "id": "d",
          "text": "d) Acquired immunity",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q23_71fe1cc9",
      "question": "Which one of the following is an example of tertiary prevention?",
      "points": 10,
      "explanation": "Explanation: Tertiary prevention aims to reduce disability and restore function (Rehabilitation) after a significant disease event like a stroke.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Hospice care",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Occupational therapy following a stroke",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Post exposure prophylaxis for rabies",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Treatment of essential hypertension",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q24_46bb1415",
      "question": "----- Measure the part of population that is affected by disease or other health related event compared to the total population",
      "points": 10,
      "explanation": "Explanation: A proportion is a fraction where the numerator (affected) is part of the denominator (total population).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Counts",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Rate",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Proportion",
          "isCorrect": true
        },
        {
          "id": "d",
          "text": "d) Ratio",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q25_5fbf786c",
      "question": "Period prevalence is obtained from one of the following studies",
      "points": 10,
      "explanation": "Explanation: Cross-sectional studies measure prevalence (point or period). Longitudinal/Cohort studies measure incidence.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Longitudinal studies",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Cross-sectional studies",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Case control studies",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Cohort studies",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q26_13aa6626",
      "question": "------ refers to the proportion of persons with clinical diseases who become severely ill or die.",
      "points": 10,
      "explanation": "Explanation: Virulence measures the severity of the disease (Cases of Severe Disease/Death divided by Total Clinical Cases).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Infertility",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Pathogenicity",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Incubation",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Virulence",
          "isCorrect": true
        }
      ]
    },
    {
      "id": "q27_169bab41",
      "question": "In order for a disease agent to survive, it should be able to do the following except",
      "points": 10,
      "explanation": "Explanation: Essential for survival: Multiply (c), Exit host (a), Infect new host (d). Changing mode of transmission is an evolutionary trait but not an immediate requirement for survival.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Emerge from a new host",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Change its mode of transmission",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Multiply",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Infect a new host",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q28_08b5bb57",
      "question": "Disease carriers can be classified into the following except",
      "points": 10,
      "explanation": "Explanation: \"Acute carrier\" is not a standard term. Types are: Asymptomatic (Healthy), Incubatory, Convalescent, and Chronic. A person with acute disease is a \"Case\", not a carrier.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Convalescent carrier",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Acute carriers",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Asymptomatic carries",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Chronic carries",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q29_ff5431b3",
      "question": "Which one of the following is not a notifiable disease?",
      "points": 10,
      "explanation": "Explanation: Polio, Yellow Fever, and Cholera are internationally notifiable diseases (PHEIC). Dysentery is reportable locally but typically not on the immediate international notification list compared to the others.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Polio",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Yellow fever",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Cholera",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Dysentery",
          "isCorrect": true
        }
      ]
    },
    {
      "id": "q30_9405e8b8",
      "question": "The following are disease related considerations during screening except",
      "points": 10,
      "explanation": "Explanation: All options are principles of screening. However, the question asks for \"Disease related considerations\". - A, C, D relate to the Disease. - B relates to the Test (not the disease itself).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) The natural history of a disease should be well known",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Test should be safe, reliable and valid",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Disease is an important serious problem in the population",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) A standard confirmatory test for the dieses is available",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q31_b04c1c72",
      "question": "The following are the sources of variability that affect the reliability of results of a screening test except",
      "points": 10,
      "explanation": "Explanation: Core sources of variation are: Biological (subject), Intra-observer (same observer), and Inter-observer (different observers). While situational conditions affect results, in standard texts, the \"three sources of variation\" are usually listed as Biological, Intra, and Inter-observer.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Intro-observer variation",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Situational conditions",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Biological variations",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Inter-observer variation",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q32_6c36ccc6",
      "question": "Another name for relative risk is",
      "points": 10,
      "explanation": "Explanation: Relative Risk is synonymous with Risk Ratio (Ratio of two risks).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Odds ratio",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Relative odds",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Risk ratio",
          "isCorrect": true
        },
        {
          "id": "d",
          "text": "d) Risk rate",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q33_e9dbd999",
      "question": "Relative risk greater than one denotes",
      "points": 10,
      "explanation": "Explanation: RR > 1 implies the risk in exposed is greater than unexposed (Positive/Harmful association).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Evidence of positive association",
          "isCorrect": true
        },
        {
          "id": "b",
          "text": "b) Evidence of negative association",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Evidence of No association",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Evidence of equal association",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q34_97229bb5",
      "question": "Which one of the following is not a type of a common source epidemic?",
      "points": 10,
      "explanation": "Explanation: Types of common source epidemics are: Point (Single), Continuous, and Intermittent (Multiple). \"Breaking\" is not a standard epidemiological term for an epidemic curve.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Multiple",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Breaking",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Single",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Continuous",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q35_b3e020d9",
      "question": "The following are components of primary prevention except one, which one?",
      "points": 10,
      "explanation": "Explanation: Slowing progression (Early diagnosis and treatment) is Secondary Prevention. Primary prevention aims to stop disease from occurring (a, b, d).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Health promotion",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Prevention of disease",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Slowing of progression of disease",
          "isCorrect": true
        },
        {
          "id": "d",
          "text": "d) Prevention of exposure",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q36_aede0cd0",
      "question": "Which one of the following is not a type of direct transmission?",
      "points": 10,
      "explanation": "Explanation: Droplet nuclei (tiny particles) remain suspended in air and cause Airborne transmission, which is classified as Indirect. Direct transmission includes Direct Contact, Droplet Spread (large particles), and Vertical (Transplacental).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Direct contact",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Direct projection",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Trans placental",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Droplet nuclei",
          "isCorrect": true
        }
      ]
    },
    {
      "id": "q37_d26b0c26",
      "question": "----- vector does not have to go through a period of multiplication or development in the Vector",
      "points": 10,
      "explanation": "Explanation: A Mechanical Vector (e.g., housefly) simply carries the pathogen on its body/feet without the pathogen undergoing biological changes (multiplication) inside the vector.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Residual",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Biological",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Mechanical",
          "isCorrect": true
        },
        {
          "id": "d",
          "text": "d) Airborne",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q38_a0810c8e",
      "question": "Which type of mortality rate reflects the risk of death in community or country",
      "points": 10,
      "explanation": "Explanation: The Crude Death Rate measures the overall mortality in the total population (community/country).",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Crude death rate",
          "isCorrect": true
        },
        {
          "id": "b",
          "text": "b) Infant mortality rate",
          "isCorrect": false
        },
        {
          "id": "c",
          "text": "c) Sex specific mortality rate",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Case fatality rate",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q39_701c9e3c",
      "question": "--- are epidemic of shorter duration covering a more limited area",
      "points": 10,
      "explanation": "Explanation: An Outbreak is essentially a localized epidemic, typically of limited duration and area.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Hyperendemic",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Out break",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Holo endermic",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Sporadic",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q40_90f8b9c2",
      "question": "Which one of the following is not a measure directed when human is the reservoir?",
      "points": 10,
      "explanation": "Explanation: Ethically and medically, we do not use \"Destruction\" (killing) as a control measure for human reservoirs. This is used for animal or insect reservoirs. Humans are treated, isolated, or quarantined.",
      "hint": null,
      "type": "multiple-choice",
      "options": [
        {
          "id": "a",
          "text": "a) Quarantine",
          "isCorrect": false
        },
        {
          "id": "b",
          "text": "b) Destruction",
          "isCorrect": true
        },
        {
          "id": "c",
          "text": "c) Isolation",
          "isCorrect": false
        },
        {
          "id": "d",
          "text": "d) Treatment",
          "isCorrect": false
        }
      ]
    },
    {
      "id": "q41_86f7ff2e",
      "question": "List and explain five advantages of passive surveillance. (5 marks) (Select all that apply)",
      "points": 15,
      "explanation": "Cost-Effective: It is relatively inexpensive as it uses existing health systems and personnel. Easy to Organize: Requires less training and infrastructure compared to active surveillance. Wide Coverage: Can cover large geographical areas and populations since it relies on routine reporting. Baseline Data: Provides good baseline data for monitoring long-term trends of disease. Sustainability: Easier to maintain over long periods because it is integrated into routine health services.",
      "hint": null,
      "type": "multiple-select",
      "options": [
        {
          "id": "opt1",
          "text": "Cost-Effective: It is relatively inexpensive as it uses existing health systems and personnel.",
          "isCorrect": true
        },
        {
          "id": "opt2",
          "text": "Easy to Organize: Requires less training and infrastructure compared to active surveillance.",
          "isCorrect": true
        },
        {
          "id": "opt3",
          "text": "Wide Coverage: Can cover large geographical areas and populations since it relies on routine reporting.",
          "isCorrect": true
        },
        {
          "id": "opt4",
          "text": "Baseline Data: Provides good baseline data for monitoring long-term trends of disease.",
          "isCorrect": true
        },
        {
          "id": "opt5",
          "text": "Sustainability: Easier to maintain over long periods because it is integrated into routine health services.",
          "isCorrect": true
        }
      ],
      "partialCredit": true
    },
    {
      "id": "q42_8ba0b7ae",
      "question": "State and explain three types of cases in the case definition of COVID-19. (5 marks) (Select all that apply)",
      "points": 15,
      "explanation": "Suspected Case: A person with acute respiratory illness (fever, cough) AND history of travel to an area with community transmission OR contact with a confirmed case. Probable Case: A suspected case for whom testing for the COVID-19 virus is inconclusive OR a suspected case for whom testing could not be performed for any reason. Confirmed Case: A person with laboratory confirmation of COVID-19 infection (e.g., Positive PCR test), irrespective of clinical signs and symptoms.",
      "hint": null,
      "type": "multiple-select",
      "options": [
        {
          "id": "opt1",
          "text": "Suspected Case: A person with acute respiratory illness (fever, cough) AND history of travel to an area with community transmission OR contact with a confirmed case.",
          "isCorrect": true
        },
        {
          "id": "opt2",
          "text": "Probable Case: A suspected case for whom testing for the COVID-19 virus is inconclusive OR a suspected case for whom testing could not be performed for any reason.",
          "isCorrect": true
        },
        {
          "id": "opt3",
          "text": "Confirmed Case: A person with laboratory confirmation of COVID-19 infection (e.g., Positive PCR test), irrespective of clinical signs and symptoms.",
          "isCorrect": true
        }
      ],
      "partialCredit": true
    },
    {
      "id": "q43_42febd64",
      "question": "Briefly explain the concept of confounding. (5 marks) (Select all that apply)",
      "points": 15,
      "explanation": "Confounding is a distortion of the association between an exposure and an outcome that occurs when a third variable (the confounder) is associated with both. Criteria for a Confounder: It must be a risk factor for the disease (outcome). It must be associated with the exposure. It must not be an intermediate step in the causal pathway between exposure and disease. Example: Studying alcohol and lung cancer. Smoking is a confounder because smokers tend to drink alcohol (associated with exposure) and smoking causes lung cancer (risk factor).",
      "hint": null,
      "type": "multiple-select",
      "options": [
        {
          "id": "opt1",
          "text": "It must be a risk factor for the disease (outcome).",
          "isCorrect": true
        },
        {
          "id": "opt2",
          "text": "It must be associated with the exposure.",
          "isCorrect": true
        },
        {
          "id": "opt3",
          "text": "It must not be an intermediate step in the causal pathway between exposure and disease.",
          "isCorrect": true
        }
      ],
      "partialCredit": true
    },
    {
      "id": "q44_82e65e43",
      "question": "Explain the concept of herd immunity. (5 marks) (Select all that apply)",
      "points": 15,
      "explanation": "Herd Immunity (Community Immunity) is the resistance of a group or community to the invasion and spread of an infectious agent based on the resistance of a high proportion of individual members of the group. It occurs when a sufficient percentage of the population is immune (via vaccination or prior infection), reducing the likelihood that an infected person will come into contact with a susceptible person. This halts the chain of transmission, protecting even those who are not immune (e.g., newborns, immunocompromised).",
      "hint": null,
      "type": "multiple-select",
      "options": [
        {
          "id": "opt1",
          "text": "It occurs when a sufficient percentage of the population is immune (via vaccination or prior infection), reducing the likelihood that an infected person will come into contact with a susceptible person.",
          "isCorrect": true
        },
        {
          "id": "opt2",
          "text": "This halts the chain of transmission, protecting even those who are not immune (e.g., newborns, immunocompromised).",
          "isCorrect": true
        }
      ],
      "partialCredit": true
    },
    {
      "id": "q45_ecb2beab",
      "question": "An area Y has a population of 100,000. 20 persons become sick of malaria in a year. 18 of the 20 persons die from malaria (5 marks) i. Calculate the mortality rate from malaria ii. Calculate the case fatality rate from malaria",
      "points": 15,
      "explanation": "i. Mortality Rate: $$ \\text{Mortality Rate} = \\frac{\\text{Deaths from Malaria}}{\\text{Total Population}} \\times 100,000 $$ $$ = \\frac{18}{100,000} \\times 100,000 = 18 \\text{ per 100,000 population} $$ ii. Case Fatality Rate (CFR): $$ \\text{CFR} = \\frac{\\text{Deaths from Malaria}}{\\text{Total Cases of Malaria}} \\times 100 $$ $$ = \\frac{18}{20} \\times 100 = 90\\% $$",
      "hint": null,
      "type": "short-answer",
      "acceptedAnswers": [
        "See explanation"
      ]
    },
    {
      "id": "q46_6875433f",
      "question": "List and explain five guidelines for judging whether an observed association is causal. (5 marks) (Select all that apply)",
      "points": 15,
      "explanation": "Based on Bradford Hill's Criteria: Strength of Association: A large Relative Risk implies a stronger likelihood of causality. Consistency: The association is observed repeatedly by different persons, in different places, circumstances, and times. Temporality: The exposure must precede the disease in time (Essential criteria). Biological Gradient (Dose-Response): Greater exposure leads to greater incidence of the effect. Plausibility: The association fits with existing biological knowledge.",
      "hint": null,
      "type": "multiple-select",
      "options": [
        {
          "id": "opt1",
          "text": "Strength of Association: A large Relative Risk implies a stronger likelihood of causality.",
          "isCorrect": true
        },
        {
          "id": "opt2",
          "text": "Consistency: The association is observed repeatedly by different persons, in different places, circumstances, and times.",
          "isCorrect": true
        },
        {
          "id": "opt3",
          "text": "Temporality: The exposure must precede the disease in time (Essential criteria).",
          "isCorrect": true
        },
        {
          "id": "opt4",
          "text": "Biological Gradient (Dose-Response): Greater exposure leads to greater incidence of the effect.",
          "isCorrect": true
        },
        {
          "id": "opt5",
          "text": "Plausibility: The association fits with existing biological knowledge.",
          "isCorrect": true
        }
      ],
      "partialCredit": true
    },
    {
      "id": "q47_ddef112a",
      "question": "List and explain five different types of epidemiology. (5 marks) (Select all that apply)",
      "points": 15,
      "explanation": "Descriptive Epidemiology: Describes disease distribution by time, place, and person. Analytical Epidemiology: Tests hypotheses to determine causes (determinants) of disease (e.g., Cohort, Case-Control). Experimental (Interventional) Epidemiology: Involves active manipulation of exposure (Clinical trials) to test efficacy. Clinical Epidemiology: Application of epidemiological principles to patient care (diagnosis, prognosis). Social Epidemiology: Studies how social structural factors affect health.",
      "hint": null,
      "type": "multiple-select",
      "options": [
        {
          "id": "opt1",
          "text": "Descriptive Epidemiology: Describes disease distribution by time, place, and person.",
          "isCorrect": true
        },
        {
          "id": "opt2",
          "text": "Analytical Epidemiology: Tests hypotheses to determine causes (determinants) of disease (e.g., Cohort, Case-Control).",
          "isCorrect": true
        },
        {
          "id": "opt3",
          "text": "Experimental (Interventional) Epidemiology: Involves active manipulation of exposure (Clinical trials) to test efficacy.",
          "isCorrect": true
        },
        {
          "id": "opt4",
          "text": "Clinical Epidemiology: Application of epidemiological principles to patient care (diagnosis, prognosis).",
          "isCorrect": true
        },
        {
          "id": "opt5",
          "text": "Social Epidemiology: Studies how social structural factors affect health.",
          "isCorrect": true
        }
      ],
      "partialCredit": true
    },
    {
      "id": "q48_ddc585a8",
      "question": "Write short notes on incidence density. (5 marks) (Select all that apply)",
      "points": 15,
      "explanation": "Definition: Incidence Density (or Incidence Rate) is the number of new cases of a disease that occur during a specified period of time in a population at risk. Denominator: Unlike cumulative incidence (which uses people), incidence density uses Person-Time (e.g., person-years) as the denominator. Usefulness: It is particularly useful when study participants are followed for varying periods of time (e.g., due to attrition or late entry). Formula: $\\text{Incidence Density} = \\frac{\\text{Number of new cases}}{\\text{Total Person-Time at risk}}$",
      "hint": null,
      "type": "multiple-select",
      "options": [
        {
          "id": "opt1",
          "text": "Definition: Incidence Density (or Incidence Rate) is the number of new cases of a disease that occur during a specified period of time in a population at risk.",
          "isCorrect": true
        },
        {
          "id": "opt2",
          "text": "Denominator: Unlike cumulative incidence (which uses people), incidence density uses Person-Time (e.g., person-years) as the denominator.",
          "isCorrect": true
        },
        {
          "id": "opt3",
          "text": "Usefulness: It is particularly useful when study participants are followed for varying periods of time (e.g., due to attrition or late entry).",
          "isCorrect": true
        },
        {
          "id": "opt4",
          "text": "Formula: $\\text{Incidence Density} = \\frac{\\text{Number of new cases}}{\\text{Total Person-Time at risk}}$",
          "isCorrect": true
        }
      ],
      "partialCredit": true
    },
    {
      "id": "q49_278d093a",
      "question": "Using a well labeled diagram, explain cohort studies with use of coronary heart disease and smoking as an example. (10 marks) (Select all that apply)",
      "points": 20,
      "explanation": "Cohort Study Design (Prospective): In a cohort study, we start with a population free of disease and classify them based on exposure status. [Diagram Structure] Start: Target Population (Free of CHD) \u2193 Select Sample & Assess Exposure (Smoking) \u2199 \u2198 Exposed Group Unexposed Group (Smokers) (Non-Smokers) \u2193 \u2193 Follow up over Time Follow up over Time \u2199 \u2198 \u2199 \u2198 Disease No Disease Disease No Disease (CHD) (No CHD) (CHD) (No CHD) Explanation: Identify a defined population (e.g., adults in a town) who do not have Coronary Heart Disease (CHD). Classify them into Smokers (Exposed) and Non-smokers (Unexposed). Follow both groups over a period (e.g., 10 years). Count how many develop CHD in the Smoker group vs. the Non-smoker group. Calculate the Relative Risk (RR) = Incidence in Smokers / Incidence in Non-smokers.",
      "hint": null,
      "type": "multiple-select",
      "options": [
        {
          "id": "opt1",
          "text": "Identify a defined population (e.g., adults in a town) who do not have Coronary Heart Disease (CHD).",
          "isCorrect": true
        },
        {
          "id": "opt2",
          "text": "Classify them into Smokers (Exposed) and Non-smokers (Unexposed).",
          "isCorrect": true
        },
        {
          "id": "opt3",
          "text": "Follow both groups over a period (e.g., 10 years).",
          "isCorrect": true
        },
        {
          "id": "opt4",
          "text": "Count how many develop CHD in the Smoker group vs. the Non-smoker group.",
          "isCorrect": true
        },
        {
          "id": "opt5",
          "text": "Calculate the Relative Risk (RR) = Incidence in Smokers / Incidence in Non-smokers.",
          "isCorrect": true
        }
      ],
      "partialCredit": true
    },
    {
      "id": "q50_33fed668",
      "question": "The following table presents the results of a screening test. Results of screening Disease (Sick) No disease (Well) Total Positive 80a (TP) 100b (FP) 180 Negative 20c (FN) 800d (TN) 820 Total 100 900 1000 Calculate: i. Sensitivity ii. Specificity iii. Positive predictive value iv. Negative predictive value",
      "points": 20,
      "explanation": "Calculations: i. Sensitivity: Ability to detect disease. $$ \\text{Sensitivity} = \\frac{\\text{True Positives (a)}}{\\text{Total Diseased (a+c)}} \\times 100 $$ $$ = \\frac{80}{100} \\times 100 = 80\\% $$ ii. Specificity: Ability to detect absence of disease. $$ \\text{Specificity} = \\frac{\\text{True Negatives (d)}}{\\text{Total Well (b+d)}} \\times 100 $$ $$ = \\frac{800}{900} \\times 100 = 88.89\\% $$ iii. Positive Predictive Value (PPV): Probability that a positive test means disease. $$ \\text{PPV} = \\frac{\\text{True Positives (a)}}{\\text{Total Positives (a+b)}} \\times 100 $$ $$ = \\frac{80}{180} \\times 100 = 44.44\\% $$ iv. Negative Predictive Value (NPV): Probability that a negative test means no disease. $$ \\text{NPV} = \\frac{\\text{True Negatives (d)}}{\\text{Total Negatives (c+d)}} \\times 100 $$ $$ = \\frac{800}{820} \\times 100 = 97.56\\% $$",
      "hint": null,
      "type": "short-answer",
      "acceptedAnswers": [
        "See explanation"
      ]
    }
  ]
}